Immunotherapy drug bolsters head and neck cancer treatment
Average of nine promotional claims on packaging of UK baby food products: study
28 February 2022Magnets in newer portable electronic devices can interfere with implanted defibrillators
1 March 2022Immunotherapy drug bolsters head and neck cancer treatment
A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.
